The state of Pennsylvania, specifically Lancaster County, is attracting major pharmaceutical investments from companies like GSK and Eli Lilly.
1 report, 1 independent
Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The state of Pennsylvania, specifically Lancaster County, is attracting major pharmaceutical investments from companies like GSK and Eli Lilly.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Eli Lilly received approval for a plant development in Pennsylvania and paid a milestone payment to Nxera Pharma.Sub-event
Pennsylvania and Lancaster County are attracting pharmaceutical investments from GSK and Eli Lilly.1 source
Keep exploring
The entities involved
-
Pennsylvania
state of the United States of America
-
Lancaster County
county in Pennsylvania, United States
- An outbreak in Lancaster County, Pennsylvania, has drawn comments from officials regarding vaccine policy, involving figures like Robert F. Kennedy Jr. and those connected to Donald Trump.
- A situation in Lancaster County, Pennsylvania, accounted for 24 percent of the national total on September 27th.
-
GlaxoSmithKline
company in Tokyo, Japan
Nothing else this week.
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Lancaster County is situated within the state of Pennsylvania.
- Governor Josh Shapiro made public health claims regarding the state of Pennsylvania.
- Jefferson County, located in Pennsylvania, is involved in the state's health data and case reporting system, which is overseen by the PA Department of Health.
- The Pennsylvania Department of State serves as the state's registration authority and operates under Pennsylvania state law.
- Camden County is part of the state's judicial system.